Diabetic ketoacidosis and insulin resistance with subcutaneous terbutaline infusion: a case report.
Diabetic ketoacidosis may occur in women treated with intravenous beta-sympathomimetic agents for tocolysis. We describe diabetic ketoacidosis and transient severe insulin resistance in a woman with diabetes who was treated with subcutaneous terbutaline infusion. Subcutaneous terbutaline infusion may precipitate transient insulin resistance and diabetic ketoacidosis in women with diabetes.
Tibaldi
J M
JM
Diabetes Control Foundation, Flushing, NY 11355.
Lorber
D L
DL
Nerenberg
A
A
D000328:Adult; D003922:Diabetes Mellitus, Type 1; D016883:Diabetic Ketoacidosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007279:Injections, Subcutaneous; D007333:Insulin Resistance; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*; D013726:Terbutaline / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D015145:Tocolysis
D013726:Terbutaline